Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | NPFFR1 | Q9GZQ6 | 1/20 | 0.38 |
| ▸ | NPFFR2 | Q9Y5X5 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.38 |
| ▸ | APLNR | P35414 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18282472 | 0.93 | MEN1 (0.41) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL19178271 | 0.89 | TDP1 (0.44) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL13678549 | 0.89 | TDP1 (0.44) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL23655994 | 0.87 | KMT2A (0.38) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL23350894 | 0.87 | TDP1 (0.43) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL24503827 | 0.87 | TDP1 (0.47) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL23465643 | 0.85 | TDP1 (0.42) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL1289840 | 0.85 | TDP1 (0.42) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL18843239 | 0.84 | MEN1 (0.42) | TDP1MAOAMAOBMEN1KMT2A | |
| SCHEMBL3984277 | 0.82 | TDP1 (0.46) | TDP1MAOAMAOBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104409-A1 | MULTIMERIC MANGANESE CONTRAST AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2026-05-21 | — | — | WO | disclosed |
| EP-4741400-A1 | MULTIMERIC MANGANESE CONTRAST AGENTS | Bayer Aktiengesellschaft (DE) | 2026-05-13 | — | — | EP | disclosed |
| US-12478696-B2 | Gadolinium chelate compounds for use in magnetic resonance imaging | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2025-11-25 | — | — | US | disclosed |
| US-20250114485-A1 | GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2025-04-10 | — | — | US | disclosed |
| US-20230113481-A1 | NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2023-04-13 | — | — | US | disclosed |
| US-11491245-B2 | Gadolinium chelate compounds for use in magnetic resonance imaging | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2022-11-08 | — | — | US | disclosed |
| US-11491245-B2 | Gadolinium chelate compounds for use in magnetic resonance imaging | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2022-11-08 | — | — | US | disclosed |
| CN-107667096-B | Novel gadolinium chelate compounds for magnetic resonance imaging | 拜耳医药股份公司 | 2021-02-02 | — | — | CN | disclosed |
| US-20200353104-A1 | GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2020-11-12 | — | — | US | disclosed |
| US-10722601-B2 | Gadolinium chelate compounds for use in magnetic resonance imaging | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2020-07-28 | — | — | US | disclosed |
| US-20190083659-A1 | GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2019-03-21 | — | — | US | disclosed |
| US-20180169274-A1 | NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-06-21 | — | — | US | disclosed |
| WO-2016193190-A1 | NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-12-08 | — | — | WO | disclosed |
| EP-0863769-B1 | GLYCOCONJUGATES AS VIRUS CELL ADHESION INHIBITORS | SYNTESOME GES FUR MED BIOCHEMI (DE) | 2002-07-03 | — | — | EP | disclosed |
| EP-0863769-A1 | GLYCOCONJUGATES AS VIRUS CELL ADHESION INHIBITORS | Syntesome Gesellschaft Fur Med. Biochemie M.B.H. (DE) | 1998-09-16 | — | — | EP | disclosed |
| EP-0863769-A2 | GLYCOCONJUGATES AS VIRUS CELL ADHESION INHIBITORS | Syntesome Gesellschaft Fur Med. Biochemie M.B.H. (DE) | 1998-09-16 | — | — | EP | disclosed |
| WO-1998014215-A2 | GLYCOCONJUGATES AS VIRUS CELL ADHESION INHIBITORS | SYNTESOME GESELLSCHAFT FÜR MED. BIOCHEMIE M.B.H. (DE) | 1998-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12478696-B2 | Gadolinium chelate compounds for use in magnetic resonance imaging | GLRA1, GLRA3, GLRB | TDP1 1272/4885MAOA 4652/4885MAOB 4339/4885 |
| US-10722601-B2 | Gadolinium chelate compounds for use in magnetic resonance imaging | GLRA1, GLRA3, GLRB | TDP1 1432/4885MAOA 4794/4885MAOB 4639/4885 |
| US-11491245-B2 | Gadolinium chelate compounds for use in magnetic resonance imaging | GLRA1, GLRA3, GLRB | TDP1 1202/4885MAOA 4733/4885MAOB 4477/4885 |
| US-20230113481-A1 | NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | GLRA1, GLRA3, GLRB | TDP1 1345/4885MAOA 4619/4885MAOB 4275/4885 |
| US-20180169274-A1 | NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | RXFP1, MAG, GLRX3 | TDP1 1709/4885MAOA 4208/4885MAOB 3745/4885 |
| US-20200353104-A1 | GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | GLRA1, GLRA3, GLRB | TDP1 1202/4885MAOA 4733/4885MAOB 4477/4885 |
| US-20250114485-A1 | GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | GLRA1, GLRA3, GLRB | TDP1 1272/4885MAOA 4652/4885MAOB 4339/4885 |
| US-20190083659-A1 | GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | GLRA1, GLRA3, GLRB | TDP1 1432/4885MAOA 4794/4885MAOB 4639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.